ACROBiosystems provides an extensive collection of recombinant Fc receptor proteins, which includes their common variants, to help accelerate the mAb development of users. To address the high ...
The binding between a biosimilar and its target antigen (and Fc receptors) is regarded as a key indicator of its efficacy. ACROBiosystems has designed high-quality target antigen proteins and Fc ...
Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...
A phase 3 trial evaluating sotatercept-csrk (Winrevair™) in adults with pulmonary arterial hypertension (PAH; World Health Organization Group 1) ...
About TX45, a long-acting Fc-relaxin fusion protein TX45 is an Fc-relaxin fusion protein with optimized pharmacokinetics and biophysical properties that activates the RXFP1 receptor, the G-protein ...
First, a series of soluble FGFR–Fc fusion proteins that contained deletions in the ECD of FGFR were generated and tested for their ability to bind to C19jun and competitively inhibit its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback